Eastwood Bio-Medical Canada(TSE:EBM)
CA$1.750.00 (0.00%)
TSE:EBM
Eastwood Bio-Medical Canada financials statements
CA$1.75
At close:0.00 (0.00%)
Want to see TSE:EBM full AI Analyst Report?
Eastwood Bio-Medical Canada (EBM) Ratios
5 Followers
Eastwood Bio-Medical Canada Ratios
TSE:EBM's free cash flow for Q3 2026 was C$-1.17K. For the 2026 fiscal year, TSE:EBM's free cash flow was increased by C$4.00 and operating cash flow was C$-1.17K. See a summary of the company’s cash flow.
| Ratios | Jan 26 | Jan 25 | Oct 23 | Oct 22 | Jan 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.02 | 0.03 | 0.11 | 0.12 | 0.07 |
| Quick Ratio | 0.02 | 0.03 | 0.11 | 0.12 | 0.07 |
| Cash Ratio | 0.01 | 0.00 | 0.01 | 0.05 | 0.03 |
| Solvency Ratio | -0.16 | -0.22 | -0.33 | -0.06 | -0.61 |
| Operating Cash Flow Ratio | 0.01 | -0.01 | -0.01 | -0.01 | -0.14 |
| Short-Term Operating Cash Flow Coverage | 0.25 | -0.19 | -0.73 | -0.16 | 0.00 |
| Net Current Asset Value | C$ -1.82M | C$ -1.53M | C$ -1.18M | C$ -777.27K | C$ -777.57K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.36 | 0.29 | 0.05 | 0.11 | 0.05 |
| Debt-to-Equity Ratio | -0.05 | -0.06 | -0.03 | -0.21 | -0.22 |
| Debt-to-Capital Ratio | -0.05 | -0.07 | -0.03 | -0.27 | -0.28 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | -0.13 | -0.28 |
| Financial Leverage Ratio | -0.13 | -0.21 | -0.58 | -1.99 | -4.79 |
| Debt Service Coverage Ratio | -3.56 | -3.98 | -8.01 | -1.13 | -180.50 |
| Interest Coverage Ratio | -39.38 | -69.63 | -17.97 | -12.03 | -211.94 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.19 | -0.23 | -0.01 | -0.69 | -0.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 64.70% | 64.72% | 50.75% | 69.45% | 46.72% |
| EBIT Margin | -45.35% | -64.04% | -59.73% | -10.71% | -61.24% |
| EBITDA Margin | -39.60% | -48.72% | -47.31% | -2.49% | -50.51% |
| Operating Profit Margin | -45.35% | -62.34% | -58.30% | -9.91% | -60.23% |
| Pretax Profit Margin | -42.55% | -64.93% | -62.98% | -11.53% | -61.53% |
| Net Profit Margin | -42.55% | -64.93% | -62.98% | -12.35% | -62.31% |
| Continuous Operations Profit Margin | -42.55% | -64.93% | -62.98% | -11.53% | -61.53% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 107.14% | 101.28% |
| EBT Per EBIT | 93.82% | 104.15% | 108.01% | 116.40% | 102.15% |
| Return on Assets (ROA) | -152.11% | -166.20% | -111.75% | -27.47% | -88.46% |
| Return on Equity (ROE) | 20.42% | 35.16% | 65.01% | 54.58% | 423.60% |
| Return on Capital Employed (ROCE) | 21.77% | 33.76% | 60.19% | 49.63% | 523.06% |
| Return on Invested Capital (ROIC) | 22.86% | 35.96% | 61.88% | 55.51% | 523.06% |
| Return on Tangible Assets | -152.11% | -166.20% | -111.75% | -27.47% | -88.46% |
| Earnings Yield | -0.69% | -0.68% | -0.99% | -0.19% | -0.61% |
| Efficiency Ratios | |||||
| Receivables Turnover | 53.49 | 16.37 | 10.48 | 89.09 | 162.88 |
| Payables Turnover | 3.27 | 3.28 | 4.20 | 6.58 | 9.86 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 4.21 | 3.04 | 2.57 | 2.91 | 1.78 |
| Asset Turnover | 3.57 | 2.56 | 1.77 | 2.22 | 1.42 |
| Working Capital Turnover Ratio | -0.47 | -0.52 | -0.90 | -1.75 | -1.92 |
| Cash Conversion Cycle | -104.86 | -88.90 | -52.06 | -51.35 | -34.77 |
| Days of Sales Outstanding | 6.82 | 22.29 | 34.82 | 4.10 | 2.24 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 111.68 | 111.20 | 86.88 | 55.45 | 37.01 |
| Operating Cycle | 6.82 | 22.29 | 34.82 | 4.10 | 2.24 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 6434.33 | 0.00 | -8444.00 | -1.43 | -20.85 |
| Capital Expenditure Coverage Ratio | 6434.33 | 0.00 | -8444.00 | -1.43 | -20.85 |
| Operating Cash Flow Coverage Ratio | 0.25 | -0.19 | -0.73 | -0.07 | -3.71 |
| Operating Cash Flow to Sales Ratio | 0.02 | -0.02 | -0.02 | -0.00 | -0.12 |
| Free Cash Flow Yield | 0.04% | -0.02% | -0.03% | -0.01% | -0.12% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -145.83 | -148.09 | -100.82 | -536.21 | -164.51 |
| Price-to-Sales (P/S) Ratio | 61.66 | 96.16 | 63.49 | 66.25 | 102.52 |
| Price-to-Book (P/B) Ratio | -29.59 | -52.06 | -65.54 | -292.69 | -696.88 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 2498.45 | -4436.37 | -3262.80 | -11797.16 | -825.81 |
| Price-to-Operating Cash Flow Ratio | 2498.07 | -4436.37 | -3263.19 | -20052.97 | -865.42 |
| Price-to-Earnings Growth (PEG) Ratio | 5.35 | 9.00 | -0.41 | 7.23 | 5.71 |
| Enterprise Value Multiple | -155.88 | -197.60 | -134.23 | -2664.25 | -202.99 |
| Enterprise Value | 48.28M | 67.59M | 55.11M | 86.13M | 100.58M |
| EV to EBITDA | -155.88 | -197.60 | -134.23 | -2664.25 | -202.99 |
| EV to Sales | 61.73 | 96.27 | 63.50 | 66.27 | 102.53 |
| EV to Free Cash Flow | 2501.58 | -4441.60 | -3263.08 | -11800.23 | -825.89 |
| EV to Operating Cash Flow | 2501.19 | -4441.60 | -3263.47 | -20058.19 | -865.51 |
| Tangible Book Value Per Share | -0.02 | -0.02 | -0.01 | -0.00 | -0.00 |
| Shareholders’ Equity Per Share | -0.02 | -0.02 | -0.01 | -0.00 | -0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.07 | -0.01 |
| Revenue Per Share | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 |
| Net Income Per Share | -0.00 | -0.01 | -0.01 | -0.00 | -0.01 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.07 | 1.01 |
| Interest Burden | 0.94 | 1.01 | 1.05 | 1.08 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 1.10 | 0.75 | 0.77 | 0.71 | 0.97 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.06 | 0.03 | 0.03 | 0.03 | 0.19 |
Currency in CAD

